Corcept Therapeutics (CORT) News Today $58.32 -1.15 (-1.93%) Closing price 04:00 PM EasternExtended Trading$59.47 +1.15 (+1.97%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Q1 EPS Forecast for Corcept Therapeutics Reduced by AnalystMarch 25 at 1:13 AM | americanbankingnews.comCibc World Markets Corp Purchases Shares of 7,567 Corcept Therapeutics Incorporated (NASDAQ:CORT)Cibc World Markets Corp acquired a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 7,567 shares of the biotecMarch 24 at 4:05 AM | marketbeat.comResearch Analysts Offer Predictions for CORT Q1 EarningsCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Analysts at Zacks Research cut their Q1 2025 earnings estimates for Corcept Therapeutics in a research report issued on Wednesday, March 19th. Zacks Research analyst K. Das now anticipates that the biotechnology company will post earMarch 24 at 1:12 AM | marketbeat.comQ2 EPS Forecast for Corcept Therapeutics Raised by AnalystCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Stock analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Corcept Therapeutics in a research note issued on Wednesday, March 19th. Zacks Research analyst K. Das now forecasts that the biotechnolMarch 22 at 6:48 AM | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Receives $99.75 Average Price Target from AnalystsMarch 22 at 2:53 AM | americanbankingnews.comZacks Research Has Optimistic Outlook of CORT Q2 EarningsMarch 22 at 1:41 AM | americanbankingnews.comIntech Investment Management LLC Boosts Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Intech Investment Management LLC increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 153.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 52,107 shares of the biotechnology company's stock after purchasing an additional 3March 21, 2025 | marketbeat.comTwin Tree Management LP Invests $306,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT)Twin Tree Management LP purchased a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 6,072 shares of the biotechnology company's stock, valued at approximatMarch 20, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Position Lifted by HighTower Advisors LLCHighTower Advisors LLC raised its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 30.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 93,677 shares of the biotechnology company's stock after purchasing an additional 22,011 shares duriMarch 20, 2025 | marketbeat.comRaymond James Financial Inc. Makes New $12.08 Million Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT)Raymond James Financial Inc. bought a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 239,803 shares of thMarch 20, 2025 | marketbeat.comProficio Capital Partners LLC Takes $1.60 Million Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Proficio Capital Partners LLC bought a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 31,695 shares of the biotechnology company's stock, valued at approximately $1,597,00March 20, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) and Gelteq (NASDAQ:GELS) Head to Head AnalysisMarch 19, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORTMarch 17, 2025 | prnewswire.comCorcept Therapeutics Incorporated (NASDAQ:CORT) is Parallel Advisors LLC's 4th Largest PositionParallel Advisors LLC boosted its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,829,632 shares of the biotechnology company's stock after purchasing an additional 1March 17, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Stake Cut by Royce & Associates LPRoyce & Associates LP lessened its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 338,300March 17, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) have been assigned a consensus rating of "Buy" from the five research firms that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation. The average 12-month prMarch 17, 2025 | marketbeat.comVictory Capital Management Inc. Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Victory Capital Management Inc. boosted its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 79.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 75,029 shares of the biotechnology company's stock after buying an additMarch 16, 2025 | marketbeat.com1 Small-Cap Stock on Our Buy List and 2 to AvoidMarch 14, 2025 | uk.finance.yahoo.comCharles Schwab Investment Management Inc. Acquires 25,073 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Charles Schwab Investment Management Inc. increased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,051,560 sharesMarch 14, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Sells 62,768 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Connor Clark & Lunn Investment Management Ltd. reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 796,795 shares ofMarch 13, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORTMarch 11, 2025 | prnewswire.comCorcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant HypertensionMarch 10, 2025 | finance.yahoo.comAssetmark Inc. Sells 6,734 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Assetmark Inc. trimmed its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,577 shares of the biotechnologMarch 10, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Intellectus Partners LLCIntellectus Partners LLC lessened its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 9.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 49,859 shares of the biotechnology company's stocMarch 9, 2025 | marketbeat.comBank of New York Mellon Corp Has $29.72 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Bank of New York Mellon Corp lessened its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 589,771 shares of the biotechnoloMarch 9, 2025 | marketbeat.comJackson Creek Investment Advisors LLC Reduces Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Jackson Creek Investment Advisors LLC lessened its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 29.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,960 sharMarch 8, 2025 | marketbeat.comLisanti Capital Growth LLC Sells 35,490 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Lisanti Capital Growth LLC reduced its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 31.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 77,665 shares of the biotechnology company's stock afterMarch 8, 2025 | marketbeat.comAre Options Traders Betting on a Big Move in Corcept Therapeutics (CORT) Stock?March 8, 2025 | msn.comOppenheimer & Co. Inc. Cuts Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Oppenheimer & Co. Inc. cut its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 35.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,000 shares of the biotechnology coMarch 6, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) CEO Joseph K. Belanoff Sells 2,924 SharesCorcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) CEO Joseph K. Belanoff sold 2,924 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $60.91, for a total transaction of $178,100.84. Following the completion of the sale, the chief executive officer now owns 3,019,411 shares in the company, valued at approximately $183,912,324.01. This trade represents a 0.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.March 5, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sean Maduck Sells 18,303 SharesCorcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider Sean Maduck sold 18,303 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $60.69, for a total value of $1,110,809.07. Following the completion of the transaction, the insider now owns 85,622 shares of the company's stock, valued at $5,196,399.18. The trade was a 17.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.March 5, 2025 | marketbeat.comA Closer Look At Corcept Therapeutics' EarningsMarch 5, 2025 | uk.finance.yahoo.comCookson Peirce & Co. Inc. Acquires Shares of 36,603 Corcept Therapeutics Incorporated (NASDAQ:CORT)Cookson Peirce & Co. Inc. acquired a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 36,603 shares of the biotechnoMarch 5, 2025 | marketbeat.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) CEO Sells 2,924 Shares of StockMarch 5, 2025 | insidertrades.comCorcept: Turning A Corner, But Risks RemainMarch 4, 2025 | seekingalpha.comCorcept Therapeutics Full Year 2024 Earnings: Misses ExpectationsMarch 4, 2025 | finance.yahoo.comPrivia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025March 4, 2025 | msn.comQ4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals StocksMarch 4, 2025 | msn.comFDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With HypercortisolismMarch 4, 2025 | finance.yahoo.comFDA files Corcept’s NDA for Relacorilant as treatment in HypercortisolismMarch 4, 2025 | markets.businessinsider.comFDA Files Corcept's New Drug Application for Relacorilant as Treatment for Patients With HypercortisolismMarch 3, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORTMarch 3, 2025 | prnewswire.comHC Wainwright Issues Pessimistic Estimate for CORT EarningsCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Analysts at HC Wainwright lowered their Q1 2025 earnings per share estimates for Corcept Therapeutics in a note issued to investors on Thursday, February 27th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology cMarch 3, 2025 | marketbeat.comMutual of America Capital Management LLC Reduces Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Mutual of America Capital Management LLC reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 15.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 219,905 shares of the bMarch 2, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Downgraded to "Hold" Rating by StockNews.comStockNews.com cut Corcept Therapeutics from a "buy" rating to a "hold" rating in a research note on Friday.March 1, 2025 | marketbeat.comHC Wainwright Issues Optimistic Outlook for CORT EarningsCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - HC Wainwright lifted their Q4 2025 earnings per share estimates for Corcept Therapeutics in a note issued to investors on Thursday, February 27th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company willMarch 1, 2025 | marketbeat.comIllumine Investment Management LLC Invests $1.03 Million in Corcept Therapeutics Incorporated (NASDAQ:CORT)Illumine Investment Management LLC acquired a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 20,481 shares of the biotechnology comMarch 1, 2025 | marketbeat.comWakefield Asset Management LLLP Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Wakefield Asset Management LLLP bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 19,707 shares of the biotechnology company's stock, valued at approximately $993,00March 1, 2025 | marketbeat.comQRG Capital Management Inc. Purchases 6,163 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)QRG Capital Management Inc. grew its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 6.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 96,365 shares of the biotechnology company's sMarch 1, 2025 | marketbeat.comVersor Investments LP Sells 12,600 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Versor Investments LP reduced its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 50.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,200 shares of the biotechnologyMarch 1, 2025 | marketbeat.com Remove Ads Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address CORT Media Mentions By Week CORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼0.830.63▲Average Medical News Sentiment CORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼187▲CORT Articles Average Week Remove Ads Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
